Medicare Enrolled
Dr. Anupama Kale, M.D.
Neurology · Amherst, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kale?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kale
Dr. Anupama Kale is a neurology specialist in Amherst, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kale performed 19,380 Medicare services across 519 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kale received a total of $67,380 from 91 pharmaceutical and/or device companies across 1067 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kale is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 5% volume in NY
$67,380 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,380
Medicare services
Top 5% in NY for neurology
519
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,211 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
15,500 | $5 | $10 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,160 | $38 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
106 | $121 | $200 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
66 | $144 | $473 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $91 | $150 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
64 | $16 | $53 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
62 | $1 | $6 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 57 | $59 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
47 | $49 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $103 | $225 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
38 | $111 | $350 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
38 | $98 | $220 |
| New patient office visit, complex (60-74 min) | 38 | $161 | $275 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
33 | $12 | $34 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
26 | $25 | $60 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
17 | $455 | $902 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
17 | $486 | $991 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
96.7% medium
2.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$67,380
Total received (2018-2024)
Avg $9,626/year across 7 years
Top 9% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
91
Companies
1,067
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,327 (37.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,168 (35.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,885 (26.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,709
2023
$25,122
2022
$10,763
2021
$14,799
2020
$2,710
2019
$1,923
2018
$2,354
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amneal Pharmaceuticals LLC
$5,385
MDD US Operations, LLC
$850
UCB, Inc.
$653
JAZZ PHARMACEUTICALS INC.
$590
ABBVIE INC.
$539
Neurocrine Biosciences, Inc.
$334
REVANCE THERAPEUTICS, INC.
$140
Alexion Pharmaceuticals, Inc.
$132
MITSUBISHI TANABE PHARMA AMERICA, INC.
$94
LivaNova USA, Inc.
$93
Alnylam Pharmaceuticals Inc.
$91
Teva Pharmaceuticals USA, Inc.
$91
Novartis Pharmaceuticals Corporation
$90
CATALYST PHARMACEUTICALS, INC.
$84
Lundbeck LLC
$66
CSL Behring
$51
Axsome Therapeutics, Inc.
$49
SK Life Science, Inc.
$42
Grifols USA, LLC
$39
Amgen Inc.
$38
PFIZER INC.
$38
HARMONY BIOSCIENCES LLC
$32
Biogen, Inc.
$29
Eisai Inc.
$28
GE HEALTHCARE
$28
Kyowa Kirin, Inc.
$24
Lilly USA, LLC
$17
SCILEX PHARMACEUTICALS INC.
$17
AstraZeneca Pharmaceuticals LP
$16
Otsuka America Pharmaceutical, Inc.
$14
TG Therapeutics, Inc.
$13
Top 3 companies account for 70.9% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$19,738
MDD US Operations, LLC
$11,287
Adamas Pharmaceuticals, Inc.
$6,882
Amneal Pharmaceuticals LLC
$6,780
Kyowa Kirin, Inc.
$3,725
Neurocrine BioSciences, Inc.
$1,800
Teva Pharmaceuticals USA, Inc.
$1,205
UCB, Inc.
$1,133
ABBVIE INC.
$1,086
Sunovion Pharmaceuticals Inc.
$1,004
ACADIA Pharmaceuticals Inc
$891
Medtronic USA, Inc.
$869
JAZZ PHARMACEUTICALS INC.
$770
Novartis Pharmaceuticals Corporation
$748
Avanir Pharmaceuticals, Inc.
$590
Alexion Pharmaceuticals, Inc.
$574
Lundbeck LLC
$537
Abbott Laboratories
$508
MITSUBISHI TANABE PHARMA AMERICA, INC.
$406
Amgen Inc.
$360
SK Life Science, Inc.
$347
Alnylam Pharmaceuticals Inc.
$339
Medtronic, Inc.
$314
Acorda Therapeutics, Inc
$307
US WorldMeds, LLC
$269
Janssen Pharmaceuticals, Inc
$253
Otsuka America Pharmaceutical, Inc.
$250
GENZYME CORPORATION
$231
Biohaven Pharmaceutical Holding Company Ltd.
$228
Ipsen Biopharmaceuticals, Inc
$210
Biogen, Inc.
$174
Eisai Inc.
$164
CSL Behring
$159
CATALYST PHARMACEUTICALS, INC.
$157
Merz Pharmaceuticals, LLC
$151
LivaNova USA, Inc.
$149
GE HEALTHCARE
$146
REVANCE THERAPEUTICS, INC.
$140
PFIZER INC.
$134
GE HealthCare
$111
Lilly USA, LLC
$110
Banner Life Sciences, LLC
$106
Inspire Medical Systems, Inc.
$102
Merz North America, Inc.
$100
Supernus Pharmaceuticals, Inc.
$95
Horizon Therapeutics plc
$93
ARBOR PHARMACEUTICALS, INC.
$93
Axsome Therapeutics, Inc.
$88
Grifols USA, LLC
$87
UPSHER-SMITH LABORATORIES LLC
$86
Azurity Pharmaceuticals, Inc.
$83
Harmony Biosciences LLC
$70
SANOFI-AVENTIS U.S. LLC
$68
Akcea Therapeutics, Inc.
$67
Greenwich Biosciences, Inc.
$58
Allergan, Inc.
$57
Avion Pharmaceuticals
$55
AbbVie Inc.
$53
Boston Scientific Corporation
$48
Catalyst Pharmaceuticals, Inc.
$44
Xeris Pharmaceuticals, Inc.
$43
GRT US Holding, Inc.
$43
Biohaven Pharmaceuticals, Inc.
$40
Mallinckrodt LLC
$38
AbbVie, Inc.
$34
HARMONY BIOSCIENCES LLC
$32
Arbor Pharmaceuticals, Inc.
$31
Upsher-Smith Laboratories LLC
$29
Assertio Therapeutics, Inc.
$28
Allergan Inc.
$26
Impax Laboratories, Inc.
$24
Sarepta Therapeutics, Inc.
$21
TG THERAPEUTICS, INC.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Octapharma USA, Inc.
$19
Terumo Medical Corporation
$19
Neos Therapeutics, LP
$18
Merck Sharp & Dohme LLC
$18
SCILEX PHARMACEUTICALS INC.
$17
E.R. Squibb & Sons, L.L.C.
$17
AstraZeneca Pharmaceuticals LP
$16
Collegium Pharmaceutical, Inc.
$16
Bausch Health US, LLC
$16
AQUESTIVE THERAPEUTICS, INC.
$15
Mallinckrodt Hospital Products Inc.
$14
TG Therapeutics, Inc.
$13
IDORSIA PHARMACEUTICALS US INC
$13
Amylyx Pharmaceuticals, Inc.
$13
Horizon Pharma plc
$13
BANNER LIFE SCIENCES, LLC
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 56.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADUHELM · AJOVY · AMYVID · APOKYN · AUBAGIO · AUSTEDO · AVONEX · AZUR · Adzenys XR-ODT · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BRIUMVI · Betaseron · Briviact · CREXONT · Cambia · DAXXIFY · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · Exondys 51 · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · KOSELUGO · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · LYVISPAH · Leqembi · MAYZENT · MYOBLOC · NORTHERA · NOURIANZ · NO_PRODUCT · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OCTRODE · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ongentys · Ponvory · Privigen · Proclaim IPG · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · RELYVRIO · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VYALEV · VYEPTI · WAINUA · WAKIX · WELLBUTRIN · Wakix · XADAGO · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (38%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for neurology in NY.
Geographic Context
Neurologists within 10 mi
73
Per 100K population
7.7
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kale is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with mixed engagement industry engagement in the top 9% of NY peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kale experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kale performed 15,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kale receive payments from pharmaceutical companies?
Yes. Dr. Kale received a total of $67,380 from 91 companies across 1,067 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kale's costs compare to other neurologists in Amherst?
Dr. Kale's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Amherst
Browse neurologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
MDD US Operations, LLC Payments to Doctors
See all physicians who received payments from MDD US Operations, LLC.
By company
Adamas Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Adamas Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology